- Home
- KZIA vs AZI Comparison
KZIA vs AZI Comparison
Compare KZIA & AZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZIA
- AZI
- Stock Information
- Founded
- KZIA 1994
- AZI 2010
- Country
- KZIA Australia
- AZI China
- Employees
- KZIA N/A
- AZI N/A
- Industry
- KZIA Biotechnology: Pharmaceutical Preparations
- AZI
- Sector
- KZIA Health Care
- AZI
- Exchange
- KZIA Nasdaq
- AZI Nasdaq
- Market Cap
- KZIA 11.7M
- AZI 11.4M
- IPO Year
- KZIA 1999
- AZI 2024
- Fundamental
- Price
- KZIA $7.56
- AZI $0.09
- Analyst Decision
- KZIA Strong Buy
- AZI
- Analyst Count
- KZIA 3
- AZI 0
- Target Price
- KZIA $16.00
- AZI N/A
- AVG Volume (30 Days)
- KZIA 72.8K
- AZI 32.4M
- Earning Date
- KZIA 12-26-2025
- AZI 01-01-0001
- Dividend Yield
- KZIA N/A
- AZI N/A
- EPS Growth
- KZIA N/A
- AZI N/A
- EPS
- KZIA N/A
- AZI N/A
- Revenue
- KZIA $1,246,312.00
- AZI $156,466,000.00
- Revenue This Year
- KZIA N/A
- AZI N/A
- Revenue Next Year
- KZIA N/A
- AZI N/A
- P/E Ratio
- KZIA N/A
- AZI N/A
- Revenue Growth
- KZIA N/A
- AZI 32.90
- 52 Week Low
- KZIA $2.86
- AZI $0.08
- 52 Week High
- KZIA $34.40
- AZI $3.10
- Technical
- Relative Strength Index (RSI)
- KZIA 54.09
- AZI 27.44
- Support Level
- KZIA $7.18
- AZI $0.08
- Resistance Level
- KZIA $7.99
- AZI $0.15
- Average True Range (ATR)
- KZIA 0.46
- AZI 0.02
- MACD
- KZIA 0.03
- AZI 0.00
- Stochastic Oscillator
- KZIA 72.19
- AZI 14.57
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.
About AZI Autozi Internet Technology (Global) Ltd. Class A Ordinary Shares
Autozi Internet Technology (Global) Ltd provides high-quality, affordable, and professional one-stop automotive products and services through online and offline channels in China. Leveraging its online supply chain cloud platform, SaaS platforms, and the network of MBS stores, It has established an ecosystem of lifecycle automotive services by connecting automotive manufacturers, auto parts manufacturers, and insurance companies with MBS stores and various automotive owners. Its business segments include new car sales, auto parts and auto accessories sales, and automotive insurance-related services. The majority of revenue is from the new car sales segment, and auto parts & auto accessories sales.